These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9821542)
21. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area. Mahmoodi G; Ahmadi S; Pourmotabbed A; Oryan S; Zarrindast MR Neurobiol Learn Mem; 2010 Jul; 94(1):83-90. PubMed ID: 20403448 [TBL] [Abstract][Full Text] [Related]
22. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. Bertaina-Anglade V; Enjuanes E; Morillon D; Drieu la Rochelle C J Pharmacol Toxicol Methods; 2006; 54(2):99-105. PubMed ID: 16750402 [TBL] [Abstract][Full Text] [Related]
23. The effects of different types of pre-training on the rat's retention performance in a swim-to-platform task following administration of scopolamine. Caldji C; Vanderwolf CH Behav Brain Res; 1996 Oct; 80(1-2):217-20. PubMed ID: 8905146 [TBL] [Abstract][Full Text] [Related]
24. Scopolamine effects on memory retention in mice: a model of dementia? Flood JF; Cherkin A Behav Neural Biol; 1986 Mar; 45(2):169-84. PubMed ID: 3964171 [TBL] [Abstract][Full Text] [Related]
25. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat. Yamaguchi Y; Kobayashi H Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360 [TBL] [Abstract][Full Text] [Related]
26. The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice. Feiro O; Gould TJ Pharmacol Biochem Behav; 2005 Feb; 80(2):251-62. PubMed ID: 15680178 [TBL] [Abstract][Full Text] [Related]
27. Glucose attenuates the effect of combined muscarinic-nicotinic receptor blockade on spontaneous alternation. Ragozzino ME; Arankowsky-Sandoval G; Gold PE Eur J Pharmacol; 1994 Apr; 256(1):31-6. PubMed ID: 8026561 [TBL] [Abstract][Full Text] [Related]
33. Testosterone potentiates scopolamine-induced disruptions of nonspatial learning in gonadectomized male rats. Leonard ST; Moerschbaecher JM; Winsauer PJ Exp Clin Psychopharmacol; 2007 Feb; 15(1):48-57. PubMed ID: 17295584 [TBL] [Abstract][Full Text] [Related]
34. Cholinergic agents and delay-dependent performance in the rat. Buxton A; Callan OA; Blatt EJ; Wong EH; Fontana DJ Pharmacol Biochem Behav; 1994 Dec; 49(4):1067-73. PubMed ID: 7886077 [TBL] [Abstract][Full Text] [Related]
35. Persistence of retrieval enhancement by amphetamine following scopolamine-induced amnesia. Quartermain D; Jung H Pharmacol Biochem Behav; 1989 May; 33(1):51-4. PubMed ID: 2780787 [TBL] [Abstract][Full Text] [Related]
36. Blood glucose and brain function: interactions with CNS cholinergic systems. Stone WS; Cottrill KL; Walker DL; Gold PE Behav Neural Biol; 1988 Nov; 50(3):325-34. PubMed ID: 3202815 [TBL] [Abstract][Full Text] [Related]
37. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine of a radial-arm maze. Fader AJ; Johnson PE; Dohanich GP Pharmacol Biochem Behav; 1999 Apr; 62(4):711-7. PubMed ID: 10208377 [TBL] [Abstract][Full Text] [Related]
38. Different effects of scopolamine on the retrieval of spatial memory and fear memory. Huang ZB; Wang H; Rao XR; Zhong GF; Hu WH; Sheng GQ Behav Brain Res; 2011 Aug; 221(2):604-9. PubMed ID: 20553767 [TBL] [Abstract][Full Text] [Related]
39. The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats. Ballard TM; McAllister KH Psychopharmacology (Berl); 1999 Sep; 146(1):10-8. PubMed ID: 10485959 [TBL] [Abstract][Full Text] [Related]
40. NMDA antagonists potentiate scopolamine-induced amnesic effect. Li HB; Matsumoto K; Tohda M; Yamamoto M; Watanabe H Behav Brain Res; 1997 Feb; 83(1-2):225-8. PubMed ID: 9062690 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]